Baxter International Inc. (BAX) compounding analysis
Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
- Score
- 18/100
- 10Y CAGR
- 1.2%
- Median YoY
- 4.3%
- YoY volatility
- σ 11.6pp· uneven
- Quarters ≥ 20%
- 1 of 40
- Negative quarters
- 9
- Valuation vs own 10Y history
- Latest historical P/S 1.1x · 10Y median 2.9x · 9th percentile · as of Oct 2, 2026
How this score is computed
- Quarters at or above 20%: 1 of 40 → 1 of 40 pts
- Steadiness (typical swing 11.6pp) → 16.7 of 25 pts
- Pace (median 4.3% YoY) → 0 of 20 pts
- Latest quarter (5.3% YoY) → 0 of 15 pts
- Score: 18 of 100
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Across metrics · 10Y
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 1.2% | 4.3% | 11.6pp | 1 of 40 | 9 |
| EPSEPS | — | -15.3% | 62.7pp | 10 of 40 | 22 |
| Op cash flowOperating cash flow | -7.1% | -2.1% | 51.1pp | 14 of 40 | 20 |
| EBITDAEBITDA | -5.7% | 1.6% | 34.6pp | 12 of 40 | 17 |
| FCFFree cash flow | -9.3% | -23.6% | 61.0pp | 13 of 40 | 19 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: BAX on the compounders surface · All compounders, ranked